Disease | hartnup disease |
Comorbidity | C0025202|malignant melanoma |
Sentences | 1 |
PubMedID- 25687848 | There is no standard second-line regimen for malignant melanoma patients with disease progression after first-line chemotherapy, even though progression-free survival (pfs) is short in malignant melanoma. |
Page: 1